Clinical trial / 2006
Oral green tea catechins reduced prostate cancer incidence in high-grade prostate intraepithelial neoplasia.
A randomized double-blind trial tested daily administration of 600 mg green tea catechins versus placebo in 60 men with high-grade prostate intraepithelial neoplasia over 1 year. One tumor was diagnosed among 30 men receiving catechins (approximately 3% incidence) compared with 9 cancers among 30 men receiving placebo (30% incidence). International Prostate Symptom Scores also improved significantly in treated men with coexistent benign prostatic hyperplasia.
- Study type
- Randomized controlled trial
- Who was studied
- 60 men with high-grade prostate intraepithelial neoplasia
- What was measured
- Prostate cancer incidence and urinary symptoms
THE PAPER
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.
Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Cancer Res, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.